Table 2.
Number of deaths, crude survival probabilities with 95% CIs, and risk differences (RD) at different follow-up times, by cohort and presence of acute pancreatitis (AP).
| Danish cohort | US cohort | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Follow-up | AP (n=179) | No AP (n=12,343) | RD | AP (n=2,207) | No AP (n=35,345) | RD | ||||
| N | Survival | N | Survival | N | Survival | N | Survival | |||
| 30 days | 28 | 84.4% (78.2%, 88.9%) |
2,359 | 80.9% (80.2%, 81.6%) |
3.5% (−3.3%, 10.2%) |
431 | 80.5% (78.8%, 82.1%) |
6,487 | 81.6% (81.2%, 82.0%) |
−1.0% (−2.7%, 0.7%) |
| 6 months | 82 | 54.2% (46.7%, 61.2%) |
7,350 | 40.4% (39.6%, 41.3%) |
13.7% (3.5%, 23.9%) |
1,318 | 40.3% (38.2%, 42.3%) |
22,025 | 37.7% (37.2%, 38.2%) |
2.7% (0.4%, 5.0%) |
| 1 year | 122 | 31.8% (25.2%, 38.7%) |
9,547 | 22.6% (21.9%, 23.4%) |
9.2% (0.5%, 17.9%) |
1,691 | 23.4% (21.6%, 25.2%) |
28,142 | 20.4% (20.0%, 20.8%) |
3.1% (1.3%, 4.9%) |
| 3 years | 153 | 13.6% (8.9%, 19.2%) |
11,415 | 6.6% (6.2%, 7.1%) |
6.9% (−0.1%, 13.9%) |
2,028 | 7.1% (6.1%, 8.3%) |
33,213 | 5.0% (4.7%, 5.2%) |
2.2% (1.1%, 3.3%) |
| 5 years | 157 | 10.3% (6.1%, 15.7%) |
11,639 | 4.2% (3.8%, 4.6%) |
6.1% (−0.4%, 12.6%) |
2,065 | 4.6% (3.7%, 5.7%) |
33,715 | 2.9% (2.7%, 3.1%) |
1.7% (0.8%, 2.7%) |